SOPHARMA AD (5/2023) Received corrected tender offer addressed to the shareholders of “Sopharma” AD from “Donev Investments Holding” AD
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. Sofia, Bulgaria, January 13, 2023 – According to the requirements of art. 100t of LPOS, the Board of Directors of “Sopharma” AD (SFA: “BFB – Sofia”, SPH: Warsaw Stock Exchange) announces that on January 13, 2023, “Sopharma” AD received a corrected tender offer, registered with the Financial Supervision Commission …
Czytaj dalej
SOPHARMA AD (4/2023) Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 11 January 2023.
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 11 January 2023. Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1 kom espi zdz Informacja dystrybuowana przez: pap-mediaroom.pl
Czytaj dalej
SOPHARMA AD (3/2023) Sales revenues for December 2022
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. “Sopharma” AD (the Company) notifies that for December 2022 the Company recorded an increase in sales of 19% compared to the same month of the previous year, incl. 14% increase in domestic sales and 21% increase in export sales. Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1 kom espi zdz Pochodzenie informacji: pap-mediaroom.pl
Czytaj dalej
SOPHARMA AD (2/2023) Notification from Ivan Badinski under Art. 19 of Regulation (EU) No 596/2014 of 12 December 2022.
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. Notification from Ivan Badinski under Art. 19 of Regulation (EU) No 596/2014 of 12 December 2022. Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1 kom espi zdz Wiadomości dystrybuowane przez: pap-mediaroom.pl
Czytaj dalej
SOPHARMA AD (1/2023) Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 23 December 2022.
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 23 December 2022. Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1 kom espi zdz Pochodzenie wiadomości: pap-mediaroom.pl
Czytaj dalej
SOPHARMA AD (103/2022) Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 21 December 2022.
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 21 December 2022. Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1 kom espi zdz Pochodzenie wiadomości: pap-mediaroom.pl
Czytaj dalej
SOPHARMA AD (101/2022) Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 20 December 2022.
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 20 December 2022. Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1 kom espi zdz Pochodzenie wiadomości: pap-mediaroom.pl
Czytaj dalej
SOPHARMA AD (100/2022) Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 19 December 2022.
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 19 December 2022. Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1 kom espi zdz Źródło wiadomości: pap-mediaroom.pl
Czytaj dalej
SOPHARMA AD (99/2022) Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 15 December 2022.
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 15 December 2022. Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1 kom espi zdz Źródło dystrybucji: pap-mediaroom.pl
Czytaj dalej
SOPHARMA AD (98/2022) Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 14 December 2022.
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering. Notification from “Telso” AD under Art. 19 of Regulation (EU) No 596/2014 of 14 December 2022. Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1 kom espi zdz Dystrybucja: pap-mediaroom.pl
Czytaj dalej